Single BCG vaccination has been considered as a protective factor against asthma. However the effect of a second dose of BCG on the prevalence rate of asthma and asthma-allergic rhinitis-eczema comorbidity has not been studied exclusively among adolescents. In this ISAAC protocol-based cross sectional study we assessed the association between one single versus two doses of BCG among 2213 individuals aged 13-14 years old. We found no association between BCG revaccination and asthma, associated (OR = 0.68, 95% CI, 0.37-1.25) or not to allergic rhinitis and/or atopic eczema (OR = 1.07, 95% CI, 0.84-1.36).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.rmed.2012.10.009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
BCG's role in strengthening immune responses: Implications for tuberculosis and comorbid diseases.
Infect Genet Evol
January 2025
Department of Life Sciences, Sharda School of Basic Sciences and Research, Sharda University, Knowledge Park III, Greater Noida, Uttar Pradesh 201306, India. Electronic address:
The BCG vaccine represents a significant milestone in the prevention of tuberculosis (TB), particularly in children. Researchers have been developing recombinant BCG (rBCG) variants that can trigger lasting memory responses, thereby enhancing protection against TB in adults. The breakdown of immune surveillance is a key link between TB and other communicable and non-communicable diseases.
View Article and Find Full Text PDFEarly introduction of IL-10 weakens BCG revaccination's protection by suppressing CD4Th1 cell responses.
J Transl Med
December 2024
Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Hubei Key Laboratory of Drug Target Research and Pharmacodynamic Evaluation, Huazhong University of Science and Technology, Wuhan, China.
Article Synopsis
- The BCG vaccine, the only current vaccine for tuberculosis (TB), shows limited effectiveness in protecting adolescents and adults from active TB, which highlights the need for better understanding of its mechanisms and potential improvements.
- A study conducted on C57BL/6J mice evaluated the effects of BCG vaccination, particularly analyzing cytokine changes, IL-10 expression across various organs, and the immune response following booster doses.
- Results indicated that IL-10 levels increased significantly in the lungs and other organs after revaccination, and blocking IL-10 signaling led to enhanced immune responses, suggesting that targeting IL-10 could improve the vaccine's effectiveness against TB.
Trends and inequalities in BCG immunisation coverage among one-year-olds in Sierra Leone, 2008-2019.
BMC Public Health
November 2024
REMS Consultancy Services Limited, Sekondi-Takoradi, Western Region, Ghana.
Article Synopsis
- BCG vaccination is crucial for preventing tuberculosis in children, but Sierra Leone struggles with achieving high and equitable vaccination rates, prompting a study on changes in BCG coverage from 2008 to 2019.
- The study utilized data from the Sierra Leone Demographic and Health Surveys to analyze inequalities in vaccination rates based on factors like maternal age, education level, economic status, and geographic location.
- Results showed that overall BCG coverage improved significantly, with increased age-related inequalities and decreased economic-related inequalities, indicating more equitable access to vaccinations among wealthier families, while disparities based on maternal education also declined.
Field Trial with Vaccine Candidates Against Bovine Tuberculosis Among Likely Infected Cattle in a Natural Transmission Setting.
Vaccines (Basel)
October 2024
Instituto de Agrobiotecnología y Biología Molecular (IABiMo), UEDD CONICET-INTA, Centro de Investigación en Ciencias Veterinarias y Agronómicas (CICVyA)-CNIA, Hurlingham 1686, Buenos Aires Province, Argentina.
Article Synopsis
- * In a trial, 74 heifers were vaccinated with different strains and then exposed to naturally infected animals, but the initial vaccination did not produce an adequate immune response, and re-vaccination did not show significant protection against the disease.
- * The study found a 23% transmission of wild-style strains in non-vaccinated animals, and while some vaccine candidates showed promise in reducing lesions, overall results indicated that further evaluation is needed, as current vaccines did not ensure improved outcomes.
The effect of BCG revaccination on the response to unrelated vaccines in urban Ugandan adolescents (POPVAC C): an open-label, randomised controlled trial.
Lancet Glob Health
November 2024
Immunomodulation and Vaccines Focus Area, Vaccine Research Theme, Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.
Background: Immune responses induced by several important vaccines differ between populations, with reduced responses in low-income and rural settings compared with high-income and urban settings. BCG immunisation boosts immune responses to some unrelated vaccines in high-income populations. We aimed to test the hypothesis that BCG revaccination can enhance responses to unrelated vaccines in Ugandan schoolchildren.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!